is this what sets isn apart?

non invasive application.
if you read the past isn announcements they have always eluded to their main market being the young (kids), very sick and the elderly due the non invasive application of the product. this is imo what sets it apart from the rest, and i assume why many first got involved with this company.
the only other biotech i touch is lct (sorry not trying to x promote). what sets them apart is there is no need for immuno suppressant drugs.
every biotech has a competitor. so dyor and decide does isn have something that sets them apart from their competitors. imo being non invasive does set them apart and gives them a hold on a niche of the market.
look at the board. reputations are on the line here. these guys/gals are all at an age where $ is or should not be the driving factor for them. they believe they can make a difference to the overall health of people in this area.
all imo dyor